EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Deubiquitylating Enzymes in Hepatocellular Carcinoma

Xingyu Mi, Qingfeng Li, Guo Long, Yilin Pan, Yulin Xie, Shiqi Lu, Liang Xiao, Jianing Tang, Ledu Zhou

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.113193 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Xingyu Mi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan 410078, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Deubiquitinating Enzymes. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination is a reversible and dynamic process, precisely regulated by ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), ubiquitin ligases (E3), and deubiquitinating enzymes (DUBs). Dysregulation of DUBs disrupts the dynamic balance of ubiquitination, contributing to the development of various diseases, particularly cancer. An increasing number of studies have identified dysregulation of DUBs in various tumor types and have explored their regulatory mechanisms in these contexts. Hepatocellular carcinoma (HCC), the most common form of liver cancer, is highly malignant and has limited treatment options, necessitating the exploration of additional therapeutic strategies. Current research has identified dysregulation of DUBs in HCC, but their mechanisms of action remain poorly understood. Given the large number of DUB family members, there is significant potential for further investigation. This review summarizes the DUBs associated with HCC, including their structures, functions, and the mechanisms through which they regulate HCC development. Furthermore, we provide a brief overview of the discussed DUBs, aiming to offer new perspectives for future HCC research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDeubiquitinating EnzymesHumansUbiquitinationAnimals

Stichwörter der Autor:innen

deubiquitylating enzymeshepatocellular carcinoma

Substanzen

Deubiquitinating Enzymes

Autor:innen und Institutionen

  • Department of Liver Surgery, Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan 410078, China.
  • Department of General Surgery, The Second Hospital of Liling City, Baitutang Town, Liling City, Zhuzhou City, Hunan 412207, China.

Zitieren

APA

Mi, X., Li, Q., Long, G., Pan, Y., Xie, Y., Lu, S., Xiao, L., Tang, J., & Zhou, L. (2025). Deubiquitylating Enzymes in Hepatocellular Carcinoma. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.113193

Vancouver

Mi X, Li Q, Long G, Pan Y, Xie Y, Lu S, et al. Deubiquitylating Enzymes in Hepatocellular Carcinoma. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.113193

BibTeX
@article{Mi2025,
  author = {Mi, Xingyu and Li, Qingfeng and Long, Guo and Pan, Yilin and Xie, Yulin and Lu, Shiqi and Xiao, Liang and Tang, Jianing and Zhou, Ledu},
  title = {Deubiquitylating Enzymes in Hepatocellular Carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.113193}
}
Kostenlos starten →